Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

This publication has 14 references indexed in Scilit:

• Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir
  Molecular Pharmacology, 2007
• Mechanism of Active Renal Tubular Efflux of Tenofovir
  Antimicrobial Agents and Chemotherapy, 2006
• Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters
  British Journal of Clinical Pharmacology, 2006
• Human renal organic anion transporters: Characteristics and contributions to drug and drug metabolite excretion
  Pharmacology & Therapeutics, 2006
• Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites
  Xenobiotica, 2005
• Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6)
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy
  Antimicrobial Agents and Chemotherapy, 2005
• Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study
  Nephrology Dialysis Transplantation, 2005
• Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites
  American Journal of Physiology-Renal Physiology, 2005
• Fanconi syndrome and renal failure induced by tenofovir: A first case report
  American Journal of Kidney Diseases, 2002